Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Litwin

Cytometry. Part B, Clinical cytometry

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteriaBrent Wood, Dragan Jevremovic, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|December 19, 2017
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 - assay validation and quality assuranceTeri Oldaker, Liam Whitby, Maryam Saber, et al.
Cytometry. Part B, Clinical Cytometry|November 18, 2020
Flow cytometric method transfer: Recommendations for best practiceMaciej Cabanski, Teri Oldaker, Jennifer J Stewart, et al.
Cytometry. Part B, Clinical Cytometry|September 17, 2020
High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare eventsUlrike Sommer, Steven Eck, Laura Marszalek, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trialsTerrence L Fisher, Jennifer Seils, Christine Reilly, et al.
Cytometry. Part B, Clinical Cytometry|December 1, 2020
Best practices for optimization and validation of flow cytometry-based receptor occupancy assaysEd Hilt, Yongliang S Sun, Thomas W McCloskey, et al.
Cytometry. Part B, Clinical Cytometry|December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesGhanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry|December 26, 2015
Role of receptor occupancy assays by flow cytometry in drug developmentJennifer J Stewart, Cherie L Green, Nicholas Jones, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Recommendations for the development and validation of flow cytometry-based receptor occupancy assaysCherie L Green, Jennifer J Stewart, Carl-Magnus Högerkorp, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteriaBrent Wood, Dragan Jevremovic, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|December 19, 2017
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 - assay validation and quality assuranceTeri Oldaker, Liam Whitby, Maryam Saber, et al.
Cytometry. Part B, Clinical Cytometry|November 18, 2020
Flow cytometric method transfer: Recommendations for best practiceMaciej Cabanski, Teri Oldaker, Jennifer J Stewart, et al.
Cytometry. Part B, Clinical Cytometry|September 17, 2020
High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare eventsUlrike Sommer, Steven Eck, Laura Marszalek, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trialsTerrence L Fisher, Jennifer Seils, Christine Reilly, et al.
Cytometry. Part B, Clinical Cytometry|December 1, 2020
Best practices for optimization and validation of flow cytometry-based receptor occupancy assaysEd Hilt, Yongliang S Sun, Thomas W McCloskey, et al.
Cytometry. Part B, Clinical Cytometry|December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesGhanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry|December 26, 2015
Role of receptor occupancy assays by flow cytometry in drug developmentJennifer J Stewart, Cherie L Green, Nicholas Jones, et al.
Cytometry. Part B, Clinical Cytometry|November 14, 2015
Recommendations for the development and validation of flow cytometry-based receptor occupancy assaysCherie L Green, Jennifer J Stewart, Carl-Magnus Högerkorp, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelinesSara A Monaghan, Steven Eck, Silvia Bunting, et al.
Pageof 1